Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model

Interleukin-1 (IL-1) is a mediator in some critical conditions such as septic shock and multiple organ failure. Acute pancreatitis is one of the noted causes of multiple organ failure but the mechanism by which local inflammation progresses to systemic disease is unknown. In this study, we used an I...

Full description

Saved in:
Bibliographic Details
Published inCritical care medicine Vol. 23; no. 5; p. 901
Main Authors Tanaka, N, Murata, A, Uda, K, Toda, H, Kato, T, Hayashida, H, Matsuura, N, Mori, T
Format Journal Article
LanguageEnglish
Published United States 01.05.1995
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Interleukin-1 (IL-1) is a mediator in some critical conditions such as septic shock and multiple organ failure. Acute pancreatitis is one of the noted causes of multiple organ failure but the mechanism by which local inflammation progresses to systemic disease is unknown. In this study, we used an IL-1 receptor antagonist (IL-1ra) to investigate whether multiple organ failure due to acute pancreatitis is mediated by IL-1, as in other causes such as severe infection, trauma, and major surgery. Prospective, randomized, controlled trial. Research laboratory of a university medical school. Specific pathogen-free male Wistar rats weighing 200 to 250 g. Necrotizing pancreatitis was induced by retrograde injection of deoxycholate solution into the biliopancreatic duct. IL-1ra was injected intravenously at a dose of 10 mg/kg 15 mins before induction of acute pancreatitis and then infused continuously at a rate of 5 mg/kg/hr for the following 24 hrs. Although treatment with recombinant human IL-1ra did not affect the degree of local pancreatic insult, it significantly reduced mortality, improved urine output as an indicator of the state of shock, and ameliorated the accumulation of neutrophils into the lung in a rat experimental pancreatitis model. We concluded that multiple organ failure in severe pancreatitis is mediated, at least in part, by IL-1 through the activation of neutrophils. Furthermore, we concluded that circulatory collapse may also be important in the mechanism of the lethal effect of pancreatitis.
AbstractList Interleukin-1 (IL-1) is a mediator in some critical conditions such as septic shock and multiple organ failure. Acute pancreatitis is one of the noted causes of multiple organ failure but the mechanism by which local inflammation progresses to systemic disease is unknown. In this study, we used an IL-1 receptor antagonist (IL-1ra) to investigate whether multiple organ failure due to acute pancreatitis is mediated by IL-1, as in other causes such as severe infection, trauma, and major surgery. Prospective, randomized, controlled trial. Research laboratory of a university medical school. Specific pathogen-free male Wistar rats weighing 200 to 250 g. Necrotizing pancreatitis was induced by retrograde injection of deoxycholate solution into the biliopancreatic duct. IL-1ra was injected intravenously at a dose of 10 mg/kg 15 mins before induction of acute pancreatitis and then infused continuously at a rate of 5 mg/kg/hr for the following 24 hrs. Although treatment with recombinant human IL-1ra did not affect the degree of local pancreatic insult, it significantly reduced mortality, improved urine output as an indicator of the state of shock, and ameliorated the accumulation of neutrophils into the lung in a rat experimental pancreatitis model. We concluded that multiple organ failure in severe pancreatitis is mediated, at least in part, by IL-1 through the activation of neutrophils. Furthermore, we concluded that circulatory collapse may also be important in the mechanism of the lethal effect of pancreatitis.
Author Kato, T
Matsuura, N
Murata, A
Mori, T
Hayashida, H
Uda, K
Tanaka, N
Toda, H
Author_xml – sequence: 1
  givenname: N
  surname: Tanaka
  fullname: Tanaka, N
  organization: Department of Surgery II, Osaka University Medical School, Japan
– sequence: 2
  givenname: A
  surname: Murata
  fullname: Murata, A
– sequence: 3
  givenname: K
  surname: Uda
  fullname: Uda, K
– sequence: 4
  givenname: H
  surname: Toda
  fullname: Toda, H
– sequence: 5
  givenname: T
  surname: Kato
  fullname: Kato, T
– sequence: 6
  givenname: H
  surname: Hayashida
  fullname: Hayashida, H
– sequence: 7
  givenname: N
  surname: Matsuura
  fullname: Matsuura, N
– sequence: 8
  givenname: T
  surname: Mori
  fullname: Mori, T
BackLink https://www.ncbi.nlm.nih.gov/pubmed/7736749$$D View this record in MEDLINE/PubMed
BookMark eNotUMtOwzAQ9KGotIVPQPIPGOzYqesjqnhUqsQFztXa3qSG1IkcB1G-gY8mha402pmVdnY1czKJbURCqOC3ght9x8eShVoyYUzJy1GxEcJMyIxzw5lURl6Sed-_j1NVajklU63lUiszIz-bmDE1OHyEyARN6LDLbaIQM9RtDH2mh9aHKmBP8x6p20OsRx4i_QwZGtqmGuJJ-8Ghp_ZIwQ0ZaUSX2hy-Q6xpB9ElhBxy-NsEmiBT_OowhQPGk814BJsrclFB0-P1uS_I2-PD6_qZbV-eNuv7LXOq5IZZqFCCkl7aVaVl4UqnVQW8lCsJTnjtLfAlOq8dGg0r4a3gytuiKgovuS8W5ObftxvsAf2uG9-AdNydUyl-AdD8ae4
CitedBy_id crossref_primary_10_3109_00365521_2014_926983
crossref_primary_10_1016_j_freeradbiomed_2011_11_009
crossref_primary_10_1159_000070727
crossref_primary_10_15369_sujms1989_15_201
crossref_primary_10_1159_000018746
crossref_primary_10_1089_107999099313785
crossref_primary_10_1097_00003246_200108000_00010
crossref_primary_10_1097_00000658_200201000_00009
crossref_primary_10_3892_etm_2015_2270
crossref_primary_10_1016_S0039_6060_98_70106_0
crossref_primary_10_1111_j_1440_1746_1998_tb00600_x
crossref_primary_10_3748_wjg_v9_i2_373
crossref_primary_10_1111_j_1939_1676_2012_00949_x
crossref_primary_10_1080_13651820310001108
crossref_primary_10_1517_13543784_8_7_973
crossref_primary_10_1016_S0140_6736_03_13139_X
crossref_primary_10_1159_000056106
crossref_primary_10_1080_003655201753265532
crossref_primary_10_1016_j_jamcollsurg_2005_10_010
crossref_primary_10_1517_14656566_4_2_235
crossref_primary_10_1097_01_shk_0000184285_57375_bc
crossref_primary_10_1097_MPA_0000000000002343
crossref_primary_10_1177_17562848231202133
crossref_primary_10_1007_s11605_019_04411_w
crossref_primary_10_1016_S0039_6109_05_70042_6
crossref_primary_10_1016_j_bcp_2014_12_016
crossref_primary_10_1016_S1091_255X_98_80109_1
crossref_primary_10_3748_wjg_v20_i45_16935
crossref_primary_10_1016_S0210_5691_03_79881_7
crossref_primary_10_3748_wjg_v20_i41_15200
crossref_primary_10_1164_rccm_2204019
crossref_primary_10_1016_S0039_6060_96_80296_0
crossref_primary_10_4292_wjgpt_v8_i1_10
crossref_primary_10_1089_jir_1997_17_113
crossref_primary_10_1159_000069148
crossref_primary_10_1016_S0016_5085_00_70271_X
crossref_primary_10_1097_01_shk_0000191413_94461_b0
crossref_primary_10_1097_00000658_199806000_00004
crossref_primary_10_1053_j_gastro_2011_03_041
crossref_primary_10_1007_s11605_007_0175_2
crossref_primary_10_1097_01_CCM_0000081428_35729_73
crossref_primary_10_1016_j_biopha_2011_11_017
crossref_primary_10_1006_jsre_1997_5174
crossref_primary_10_1016_S1441_2772_23_00809_8
crossref_primary_10_1097_00003246_200007000_00064
crossref_primary_10_1016_S0002_9610_97_00240_7
crossref_primary_10_1016_j_biochi_2010_06_018
crossref_primary_10_1097_01_CCM_0000150661_69565_D8
crossref_primary_10_1111_j_1600_079X_2010_00808_x
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1097/00003246-199505000-00019
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 7736749
Genre Journal Article
GroupedDBID ---
.-D
.3C
.55
.GJ
.XZ
.Z2
01R
0R~
1J1
354
3O-
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
6J9
6PF
71W
77Y
7O~
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AAQQT
AARTV
AASCR
AASOK
AASXQ
AAUEB
AAWTL
AAXQO
AAYEP
AAYOK
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABPPZ
ABVCZ
ABXVJ
ABZAD
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACIJW
ACILI
ACLDA
ACOAL
ACWDW
ACWRI
ACXJB
ACXNZ
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFDTB
AFEXH
AFFNX
AFSOK
AFUWQ
AGINI
AHOMT
AHQNM
AHRYX
AHVBC
AI.
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BOYCO
BQLVK
BS7
BYPQX
C45
CGR
CS3
CUY
CVF
DIWNM
DU5
DUNZO
E.X
EBS
ECM
EEVPB
EIF
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GNXGY
GQDEL
H0~
HLJTE
HZ~
IE0
IKREB
IKYAY
IN~
IPNFZ
J5H
JF9
JG8
JK3
JK8
K-A
K-F
K8S
KD2
KMI
L-C
L7B
M18
N4W
N9A
NEJ
NPM
N~7
N~B
N~M
O9-
OAG
OAH
OB4
OBH
OCUKA
ODA
ODMTH
ODZKP
OHH
OHT
OHYEH
OJAPA
OL1
OLB
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
ONV
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PKN
PONUX
R58
RIG
RLZ
S4R
S4S
T8P
TEORI
TSPGW
V2I
VH1
VVN
W3M
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YCJ
YFH
YOC
YOJ
ZCG
ZFV
ZGI
ZXP
ZY1
ZZMQN
~9M
ID FETCH-LOGICAL-c4509-bafe3a43d3b8f732c5c74fa05383ac1d7dba06ecd7ce97a81db104db2f22d30d2
ISSN 0090-3493
IngestDate Wed Feb 19 02:35:55 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4509-bafe3a43d3b8f732c5c74fa05383ac1d7dba06ecd7ce97a81db104db2f22d30d2
PMID 7736749
ParticipantIDs pubmed_primary_7736749
PublicationCentury 1900
PublicationDate 1995-May
PublicationDateYYYYMMDD 1995-05-01
PublicationDate_xml – month: 05
  year: 1995
  text: 1995-May
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Critical care medicine
PublicationTitleAlternate Crit Care Med
PublicationYear 1995
SSID ssj0014573
Score 1.7526121
Snippet Interleukin-1 (IL-1) is a mediator in some critical conditions such as septic shock and multiple organ failure. Acute pancreatitis is one of the noted causes...
SourceID pubmed
SourceType Index Database
StartPage 901
SubjectTerms Acute Disease
Animals
Deoxycholic Acid
Disease Models, Animal
Drug Evaluation, Preclinical
Interleukin 1 Receptor Antagonist Protein
Interleukin-1 - administration & dosage
Male
Multiple Organ Failure - drug therapy
Multiple Organ Failure - etiology
Necrosis
Pancreas - pathology
Pancreatitis - chemically induced
Pancreatitis - complications
Pancreatitis - drug therapy
Prospective Studies
Random Allocation
Rats
Rats, Wistar
Receptors, Interleukin-1 - antagonists & inhibitors
Receptors, Interleukin-1 - drug effects
Recombinant Proteins - administration & dosage
Sialoglycoproteins - administration & dosage
Specific Pathogen-Free Organisms
Title Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model
URI https://www.ncbi.nlm.nih.gov/pubmed/7736749
Volume 23
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LTttAFB2FViA2VVtAQB-6i-6QkR8zHmdZVa0QEqwSiR2ap2QBJgsHiXwDX8DXcudhYqcgHhsr8WisZM7Jzbkz90HILylTKqWwiS6pSKhSRYJuRJ6YLJWMSsaNcrnDJ6fl0ZQen7Gz0ei-F7U0b-WhWjyZV_IeVPEe4uqyZN-A7OND8Qa-Rnzxigjj9VUY--28SzO_qJskO0DbZWatD4p0R02uJK5rdFPb2pVxQDqEJF8fAHvjeoWElk7uvZ6roESFcnEDDWrJ67Ze-Ex1pIUXlm3tZ4oD5MywMYDvptNXuY_9E3xc2erx_UQ04kIMjoEQbtGKwdbqVIvBLqyL91kmU-iYuMeWUYGd7R2jxaehH2Jne0OuceQY6xnScZj6n4EPhYPdvywqwdKFyaCEi9nxwfb2cJ9deeA5L0pOXx5cKbwdR9bIGnogrqWq2weK51OUxdiF-J1ijFhXDvSpz7ZJ1uMTVzwYr2Qmn8mn6ILA78CnL2Rkmq9k4ySitEXuBrSCjlawpBV0tAKkFURaQd2ApxUEWkGkFchb8LSCHq2gTys3UwAyAPq0Ak-rbTL993fy5yiJTTsSRVF8Jvi7N4WghS5kZXmRK6Y4tQJtfVUIlWmupUhLozRXZswFuksyS6mWuc1zXaQ63yEfmuvG7OKKVnwsU2uta1XPDJeZyihnXLMKJVZV7pGdsI7ns1CZ5Twu8P5zA9_I5pKa38lHi4bA_EBV2cqfHuAH3714hw
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interleukin-1+receptor+antagonist+modifies+the+changes+in+vital+organs+induced+by+acute+necrotizing+pancreatitis+in+a+rat+experimental+model&rft.jtitle=Critical+care+medicine&rft.au=Tanaka%2C+N&rft.au=Murata%2C+A&rft.au=Uda%2C+K&rft.au=Toda%2C+H&rft.date=1995-05-01&rft.issn=0090-3493&rft.volume=23&rft.issue=5&rft.spage=901&rft_id=info:doi/10.1097%2F00003246-199505000-00019&rft_id=info%3Apmid%2F7736749&rft_id=info%3Apmid%2F7736749&rft.externalDocID=7736749
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0090-3493&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0090-3493&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0090-3493&client=summon